Science and Research

Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development

The tumor matrix together with inflammation and autophagy are crucial regulators of cancer development. Embedded in the tumor stroma are numerous proteoglycans which, in their soluble form, act as danger-associated molecular patterns (DAMPs). By interacting with innate immune receptors, the Toll-like receptors (TLRs), DAMPs autonomously trigger aseptic inflammation and can regulate autophagy. Biglycan, a known danger proteoglycan, can regulate the cross-talk between inflammation and autophagy by evoking a switch between pro-inflammatory CD14 and pro-autophagic CD44 co-receptors for TLRs. Thus, these novel mechanistic insights provide some explanation for the plethora of reports indicating that the same matrix-derived DAMP acts either as a promoter or suppressor of tumor growth. In this review we will summarize and critically discuss the role of the matrix-derived DAMPs biglycan, hyaluronan, and versican in regulating the TLR-, CD14- and CD44-signaling dialogue between inflammation and autophagy with particular emphasis on cancer development.

  • Roedig, H.
  • Damiescu, R.
  • Zeng-Brouwers, J.
  • Kutija, I.
  • Trebicka, J.
  • Wygrecka, M.
  • Schaefer, L.

Keywords

  • Animals
  • Autophagy
  • Biglycan/metabolism
  • Cell Transformation, Neoplastic/genetics/immunology/metabolism
  • Disease Susceptibility
  • Extracellular Matrix/*metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hyaluronan Receptors/*metabolism
  • Immunity, Innate
  • Inflammation/etiology/metabolism/pathology
  • Lipopolysaccharide Receptors/*metabolism
  • Macrophages/immunology/metabolism
  • Neoplasms/*etiology/*metabolism/pathology
  • Reactive Oxygen Species
  • *Signal Transduction
  • Toll-Like Receptors/metabolism
  • *Biglycan
  • *Hyaluronan
  • *Inflammation
  • *Toll-like receptor
  • *Versican
  • respect to the authorship and publication of this article.
Publication details
DOI: 10.1016/j.semcancer.2019.07.026
Journal: Semin Cancer Biol
Pages: 31-47 
Work Type: Review
Location: UGMLC
Disease Area: LC
Partner / Member: JLU
Access-Number: 31412297

DZL Engagements

chevron-down